World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
28137
World Ranking
1956
National Ranking
957

Harlan Robins publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Harlan Robins sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 257 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Harlan Robins D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Harlan Robins sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Harlan Robins is affiliated with Adaptive Biotechnologies in the United States and has a significant body of research primarily focused on immunology, medicine, and microbiology. Their scholarly work spans across multiple subfields, including immunology, infectious diseases, oncology, molecular biology, and genetics.

The scientist's main topics of research cover a broad spectrum of immunological and infectious disease areas. These include SARS-CoV-2 and COVID-19 research, T-cell and B-cell immunology, immune cell function and interaction, COVID-19 clinical research studies, vaccines and immunoinformatics approaches, CAR-T cell therapy research, and immunotherapy and immune responses.

Robins' publications appear predominantly in respected venues such as bioRxiv (Cold Spring Harbor Laboratory), Frontiers in Immunology, Cancer Research, Gastroenterology, and Nature, with bioRxiv hosting the highest number of their papers. Frequent co-authors in their network include Thomas M. Snyder, Rebecca Elyanow, Ian M. Kaplan, Damon May, and Bryan Howie.

Selected recent papers illustrate the scope and focus of Robins' research:

  • Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans (2021, Nature)
  • Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels (2020, bioRxiv [Cold Spring Harbor Laboratory])
  • Comprehensive T cell repertoire characterization of non-small cell lung cancer (2020, Nature Communications)
  • Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma (2020, BMC Cancer)
  • Fundamental immune-oncogenicity trade-offs define driver mutation fitness (2022, Nature)

Best Publications

  • PD-1 blockade induces responses by inhibiting adaptive immune resistance

    Paul C. Tumeh;Christina L. Harview;Jennifer H. Yearley;I. Peter Shintaku

  • Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells

    Harlan S. Robins;Paulo V. Campregher;Santosh K. Srivastava;Abigail Wacher

  • Using synthetic templates to design an unbiased multiplex PCR assay

    Christopher S. Carlson;Ryan O. Emerson;Anna M. Sherwood;Cindy Desmarais

  • Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire

    Ryan O Emerson;William S DeWitt;Marissa Vignali;Jenna Gravley

  • Overlap and Effective Size of the Human CD8+ T Cell Receptor Repertoire

    Harlan S. Robins;Santosh K. Srivastava;Paulo V. Campregher;Cameron J. Turtle

  • Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade

    Douglas B. Johnson;Garrett M. Frampton;Matthew J. Rioth;Erik Yusko

  • CTLA4 blockade broadens the peripheral T cell receptor repertoire

    Lidia Robert;Jennifer Tsoi;Xiaoyan Wang;Ryan O. Emerson

  • Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer

    Sanja Stevanović;Anna Pasetto;Sarah R. Helman;Jared J. Gartner

  • Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade.

    Simon J. Dovedi;Eleanor J. Cheadle;Amy L. Popple;Edmund Poon

  • Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis.

    Alexandra Snyder;Alexandra Snyder;Tavi Nathanson;Samuel A. Funt;Samuel A. Funt;Arun Ahuja

  • Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: Implications for latency

    Eain Murphy;Jiří Vaníček;Harlan Robins;Thomas Shenk

  • Immune surveillance by CD8αα + skin-resident T cells in human herpes virus infection

    Jia Zhu;Tao Peng;Tao Peng;Christine Johnston;Khamsone Phasouk

  • Common clonal origin of central and resident memory T cells following skin immunization

    Olivier Gaide;Ryan O Emerson;Xiaodong Jiang;Nicholas Gulati

  • Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans.

    Galit Alter;Galit Alter;Jingyou Yu;Jinyan Liu;Abishek Chandrashekar

  • Immunosequencing: applications of immune repertoire deep sequencing.

    Harlan Robins

  • Clinically resolved psoriatic lesions contain psoriasis-specific IL-17–producing αβ T cell clones

    Tiago R. Matos;John T. O’Malley;Elizabeth L. Lowry;David Hamm

  • T cell repertoire following autologous stem cell transplantation for multiple sclerosis.

    Paolo A. Muraro;Harlan Robins;Sachin Malhotra;Michael Howell

  • High-Throughput Sequencing Detects Minimal Residual Disease in Acute T Lymphoblastic Leukemia

    David Wu;Anna Sherwood;Jonathan R. Fromm;Stuart S. Winter

  • Novel technologies and emerging biomarkers for personalized cancer immunotherapy.

    Jianda Yuan;Priti S. Hegde;Raphael Clynes;Periklis G. Foukas;Periklis G. Foukas

  • Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions.

    Leonel Maldonado;Jessica E. Teague;Matthew P. Morrow;Iveta Jotova

  • Ultra-sensitive detection of rare T cell clones

    Harlan Robins;Cindy Desmarais;Jessica Matthis;Robert Livingston

  • High-throughput pairing of T cell receptor α and β sequences

    Bryan Howie;Anna M. Sherwood;Ashley D. Berkebile;Jan Berka

Frequent Co-Authors

Christopher S. Carlson
Christopher S. Carlson Fred Hutchinson Cancer Research Center
Mark J. Rieder
Mark J. Rieder University of Washington
Arnold J. Levine
Arnold J. Levine Institute for Advanced Study
Edus H. Warren
Edus H. Warren Fred Hutchinson Cancer Research Center
Thomas S. Kupper
Thomas S. Kupper Brigham and Women's Hospital
Brent L. Wood
Brent L. Wood University of Washington
Rachael A. Clark
Rachael A. Clark Brigham and Women's Hospital
Ilan R. Kirsch
Ilan R. Kirsch Adaptive Biotechnologies (United States)
Nancy L. Haigwood
Nancy L. Haigwood Oregon Health & Science University
James P. Allison
James P. Allison The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology and its applications in healthcare, pursuing related nursing degrees can offer diverse career opportunities. Transitioning from a family nurse practitioner (FNP) to an acute care role is a common pathway for professionals seeking to specialize further. Programs addressing the fnp to acute care certification streamline this process, equipping nurses with the advanced skills needed for acute patient care settings.

Accelerated study options are particularly appealing to individuals looking to fast-track their nursing qualifications. For example, the accelerated np program offers an efficient route to becoming a nurse practitioner, combining rigorous coursework with flexible online study. This is ideal for those balancing education with other commitments.

Moreover, non-nurses can enter the field through 12-month accelerated nursing programs online for non nurses, which provide an intensive foundation in nursing principles to launch careers in related health fields, including immunology research and clinical support roles.

For those starting their nursing journey, enrolling in absn programs with high acceptance rates can be a strategic choice. These programs offer greater accessibility while maintaining quality education, helping students move quickly into healthcare professions connected to immunology.

Best Scientists Citing Harlan Robins

Trending Scientists

Recently Published Articles